Eric Rubenstein, PhD, assistant professor, Department of Epidemiology, Boston University School of Public Health, explains why continued data collection for public school students with disabilities that experience homelessness is crucial for better support and care in this population.
Pediatric experts review available COVID-19 vaccines for children and provide guidance on administration and advising parents/caregivers on when to vaccinate children.
Tina Tan, MD, and Sean O’Leary, MD, comment on the importance of vaccinating children against COVID-19, as well as how vaccine recommendations are changing.
Sean O’Leary, MD, reviews the different types of tests used to detect COVID-19 and their sensitivity and accuracy.
Tina Tan, MD, and Sean O’Leary, MD, discuss the evolving understanding regarding the severity and transmissibility of COVID-19 in the pediatric population.
In part 3 of our obesity series, Candice W. Jones, MD, discusses how obesity affects mental health in children, along with how mental health can be managed in these patients.
Jessica Peck, DNP, APRN, CPNP-PC, CNE, CNL, FAANP, FAAN, pediatric nurse practitioner, discusses the vital role of nurse practitioners and key takeaways from the 44th National Association of Pediatric Nurse Practitioners Conference.
Anne Dubin, MD, division chief of pediatric cardiology at Stanford Medicine Children's Health, discusses developments made in pediatric cardiovascular care in recent decades, along with developments she hopes to see in the future.
Colleen Kraft, MD, senior medical director of clinical adoption at Cognoa, discusses how autism spectrum disorder (ASD) development affects children and families, along with how early diagnosis and treatment can improve the lives of children with ASD.
Kimberly Simmons, MD, provides resources for patients with T1D, and key takeaways for pediatricians screening for and diagnosing T1D in pediatric patients.
Tina Q. Tan, MD, and Kimberly Simmons, MD, discuss improved methods of monitoring blood glucose levels in patients with type 1 diabetes.
What treatments are currently available, or what treatments are in development, to try to slow the progression of type 1 diabetes [T1D]?
Experts consider how often a patient with a family history of type 1 diabetes needs to be retested.
Brittany Craiglow, MD, and Angela J Lamb, MD, share closing thoughts on the role of pediatricians and emerging treatments in the pipeline for pediatric AD.
Expert dermatologists review the use of dupilumab for treatment of pediatric AD, and how topical and injectable medication can impact a patient’s lifestyle.
Tina Q Tan, MD, and Kimberly Simmons, MD, discuss lifestyle changes such as a balanced diet and glucose monitoring in the management of pediatric T1D.
Tina Q Tan, MD, and Kimberly Simmons, MD, comment on early screening for pediatric T1D, screening options, and next steps once a child has tested positive for 2 or more autoantibodies.
Angela Lamb, MD, shares her approach to treatment selection for pediatric patients with AD.
Brittany Craiglow, MD, and Angela J Lamb, MD, share initial case impressions of a 7-year-old female patient with AD and discuss the key role of parents in disease management.
Tina Q. Tan, MD, FAAP, FIDSA, FPIDS, editor-in-chief of Contemporary Pediatrics, talks about the most significant moments in children’s health in 2022; what the tridemic really means for pediatric health care providers; and what we have to look forward to in 2023 when it comes to new vaccines and medications.
Alok Patel, MD, shares what pediatric health care providers should know about a concerning new strain of group A streptococcus.
Kimberly Simmons, MD, reviews stages 1, 2, and 3 of pediatric T1D progression.
Tina Q Tan, MD, and Kimberly Simmons, MD, provide an overview of the prevalence of type 1 diabetes (T1D) in pediatric patients as well as its risk factors.
Drs Brittany Craiglow and Angela Lamb provide insight on how they address access to care issues that arise for patients with pediatric AD.
Expert dermatologists discuss the role of a multidisciplinary care team in treating pediatric AD and the modes of communication between specialists and pediatricians.
Robert L. Findling, MD, MBA; and Timothy Wilens, MD, share advice on the treatment of pediatric ADHD and new agents in the pipeline.
Drs Robert L. Findling and Timothy Wilens discuss the efficacy and safety data of serdexmethylphenidate/dexmethylphenidate (SDX/d-MPH) in childhood ADHD.
Robert L. Findling, MD, MBA, and Timothy Wilens, MD, review serdexmethylphenidate-dexmethylphenidate, a combination agent recently approved for the treatment of ADHD.
Jeffrey L. Alvaro, M.D., introduces an upcoming panel discussion surrounding the clinical implications of novel drug delivery systems in the management of Pediatric ADHD, utilizing 3 patient cases.
Brittany Craiglow, MD, and Angela J Lamb, MD, review a pediatric patient’s journey to diagnosis and treatment of AD.